The future of Agios Pharmaceuticals Inc (AGIO) Stock is still in tatters?

Cantor Fitzgerald raised the price target for the Agios Pharmaceuticals Inc (NASDAQ:AGIO) stock to “an Overweight”. The rating was released on February 08, 2024, according to finviz. The research report from Goldman has upgraded the stock from Sell to Neutral, with a price target set at $32. The stock was upgraded by SVB Leerink, who […]

Agios Pharmaceuticals Inc (AGIO) Stock is the one stock you should own forever

Cantor Fitzgerald raised the price target for the Agios Pharmaceuticals Inc (NASDAQ:AGIO) stock to “an Overweight”. The rating was released on February 08, 2024, according to finviz. The research report from Goldman has upgraded the stock from Sell to Neutral, with a price target set at $32. The stock was upgraded by SVB Leerink, who […]

How Agios Pharmaceuticals Inc (AGIO) Stock converts water flow into cash flow

Cantor Fitzgerald raised the price target for the Agios Pharmaceuticals Inc (NASDAQ:AGIO) stock to “an Overweight”. The rating was released on February 08, 2024, according to finviz. The research report from Goldman has upgraded the stock from Sell to Neutral, with a price target set at $32. The stock was upgraded by SVB Leerink, who […]